大西輝特定講師（リウマチセンター）の論文がArthritis Research & Therapy誌に掲載されました。
Onishi A, Tanaka M, Fujii T, Murata K, Murakami K, Hashimoto M, Watanabe R, Nozaki Y, Ashida C, Yamamoto W, Yamada H, Sendo S, Ebina K, Makino H, Son Y, Wada Y, Hata K, Matsuda S, Morinobu A. Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study. earch . 2025 Mar 7;27(1):52. doi: 10.1186/s13075-025-03514-x. PMID: 40055759; PMCID: PMC11887301.